The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1318
Tablet Splitting
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Readers have asked us to update our 2004 article on tablet splitting.1 Breaking drug tablets in half is a common practice, but the FDA recently advised consumers against it (FDA Consumer Health Information, July 2009).

RATIONALE — Tablets are sometimes split to achieve an intermediate dose between marketed strengths. Some patients may split larger-sized tablets to facilitate swallowing. And, of course, when 2 tablet strengths cost the same, as they often do, splitting the larger strength saves money.

DOSAGE UNIFORMITY — The distribution of active drug in a whole tablet and its potential for crumbling or breaking unevenly are related to drug manufacturing quality assurance standards. In one study, using near-infrared spectroscopic imaging, large clumps of active ingredient were found in simvastatin tablets manufactured in 4 countries by secondary manufacturers, but not in ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Tablet Splitting
Article code: 1318b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian